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ABSTRACT
Objective To compare the efficacy of surgery with disc
prosthesisversusnon-surgicaltreatmentforpatientswith
chronic low back pain.
Design A prospective randomised multicentre study.
Setting Five university hospitals in Norway.
Participants 173 patients with a history of low back pain
for at least one year, Oswestry disability index of at least
30 points, and degenerative changes in one or two lower
lumbar spine levels (86 patients randomised to surgery).
PatientsweretreatedfromApril2004toSeptember2007.
Interventions Surgery with disc prosthesis or outpatient
multidisciplinary rehabilitation for 12-15 days.
Main outcome measures The primary outcome measure
was the score on the Oswestry disability index after two
years. Secondary outcome measures were low back pain,
satisfaction with life (SF-36 and EuroQol EQ-5D), Hopkins
symptom check list (HSCL-25), fear avoidance beliefs
(FABQ), self efficacy beliefs for pain, work status, and
patients’ satisfaction and drug use. A blinded
independent observer evaluated scores on the back
performance scale and Prolo scale at two year follow-up.
Results The study was powered to detect a difference of
10 points on the Oswestry disability index between the
groups at two years. At two years there was a mean
difference of −8.4 points (95% confidence interval −13.2
to −3.6) in favour of surgery. In the analysis of
prespecified secondary outcomes, there were significant
differences in favour of surgery for low back pain (mean
difference −12.2, −21.3 to −3.1), patients’ satisfaction
(63% (n=46) v 39% (n=26)), SF-36 physical component
score (mean difference 5.8, 2.5 to 9.1), self efficacy for
pain(meandifference1.0,0.2to1.9),andtheProloscale
(mean difference 0.9, 0.1 to 1.6). There were no
significant differences in return to work, SF-36 mental
componentscore,EQ-5D,fearavoidancebeliefs,Hopkins
symptom check list, drug use, and the back performance
scale. One serious complication of leg amputation
occurred during surgical revision of a polyethylene
dislodgement. The drop-out rate was 20% (34) and the
crossover rate was 6% (5).
ConclusionsSurgicalinterventionwithdiscprosthesisfor
chronic low back pain resulted in a significantly greater
improvement in the Oswestry score compared with
rehabilitation, but this improvement did not clearly
exceed the prespecified minimally important clinical
difference between groups of 10 points, and the data are
consistent with a wide range of differences between the
groups, including values well below 10 points. The
potential risks of surgery and the substantial amount of
improvement experienced by a sizeable proportion of the
rehabilitation group also have to be incorporated into
overall decision making.
Trial registration www.clinicaltrial.gov NCT 00394732.
INTRODUCTION
Lowbackpainiscommonwithalifetimeprevalenceof
about 59-84%.
1 Although relatively few patients
developchroniclowbackpainwithdisability,itrepre-
sents extensive individual, societal, and financial pro-
blems. In patients who have had longstanding or
serious disabling low back pain in the previous
12 months, a third will improve and have less serious
problems during the following year.
2 Most patients
who develop chronic low back pain, however, stay in
this condition for years.
Fusion of assumed symptomatic segments in
patients with chronic low back pain has been used
widely, but randomised studies comparing fusion
with non-surgical treatment indicate that a rehabilita-
tion programme can be as effective as surgery. Four
randomised studies have compared lumbar fusion
with non-operative treatment.
3-7 Fritzell et al found
that fusion significantly reduced pain and disability
compared with usual care.
3 Brox et al and Fairbank et
al comparedfusion with a multidisciplinary rehabilita-
tion programme focusing on cognitive intervention
and supervised exercise.
4-7 They found similar
improvement in pain and disability in the two inter-
vention groups.
During the past 25 years, insertion of a disc prosthe-
sis has become an option. In the four published
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fusion, the clinical outcome of disc prosthesis was at
least equivalent to that of fusion.
8-11 As surgical proce-
dures should be evaluated against non-surgical
methods,
1213wecomparedtheefficacyofdiscprosthe-
sis and a multidisciplinary rehabilitation programme.
METHODS
Study design
A multicentre study conducted at five university hos-
pitals in Norway included patients with low back pain
and degenerative discs. Patients were included in the
period between April 2004 and May 2007 and were
treated within three months after randomisation.
Theywererandomisedinblockswithawebsitehosted
bythemedicalfaculty.Allocationwasconcealedforall
people involved in the trial. A coordinating secretary
not involved in the treatment could access randomisa-
tiondetailsontheinternet.Thepatientandthetreating
unit were informed about the allocation shortly after
randomisation.Randomisationwasstratifiedbycentre
(the five university hospitals) and whether the patient
had had previous surgery (microsurgical decompres-
sion) or not. Independent observers collected and
entered data. Storage of data was allowed by the Nor-
wegian data inspectorate.
Participants
Patients were referred from all health regions in Nor-
way. They were recruited from local hospitals or pri-
mary care to their nearest university hospital as usual
without any supplemental recruitment attempt. An
orthopaedic surgeon and a specialist in physical medi-
cine and rehabilitation examined the patients before
enrolment. All patients were informed about the pro-
cedures and told that neither of the treatmentmethods
was documented as superior to the other. Eligible
patients were aged 25-55 and had low back pain as
the main symptom for at least a year, structured
physiotherapy or chiropractic treatment for at least
six months without sufficient effect, a score of at least
30 on the Oswestry disability index, and degenerative
intervertebraldiscchangesinL4/L5orL5/S1,orboth.
Degeneration had to be restricted to the two lower
levels. We evaluated the following degenerative
changes: at least 40% reduction of disc height,
14
Modic changes type I or II, or both,
15 high intensity
zone in the disc,
16 and morphological changes classi-
fied as changes in signal intensity in the disc of grade
3o r4 .
17 The disc was classified as degenerative if the
first criterion alone or at least two changes were found
on magnetic resonance imaging. The discs were inde-
pendently classified by two observers (orthopaedic
surgeon/radiologist). When there was disagreement,
a third observer classified the images and the outcome
was decided by simple majority.
Degenerationofthefacetjointswasnotanexclusion
criterion, but symptoms of nerve root involvement
were. Details of further inclusion and exclusion cri-
teria, compliance with randomisation, and drop-outs
are listed in the appendix 1 on bmj.com.
Study interventions
Rehabilitation—The rehabilitation was based on the
treatmentmodeldescribedbyBroxetal
4andconsisted
of a cognitive approach and supervised physical exer-
cise. A team of physiotherapists and specialists in phy-
sical medicine and rehabilitation directed the
multidisciplinary treatment. Other specialists, such as
psychologists, nurses, social workers, etc, could com-
plete the team. The intervention was standardised
throughthreeseminarsandvideosandlecturesessions
forthetreatmentprovidersbeforethestudy.Theinter-
vention was organised as an outpatient treatment in
groups at the involved university hospitals and lasted
for about 60 hours over three to five weeks. The treat-
ment consisted of lectures and individual discussions
focusing on relevant topics (such as anatomy and the
3 patients excluded shortly after randomisation†
Allocated to rehabilitation (n=87)
Started allocated intervention (n=80)
Did not start allocated intervention (n=7)
3 patients excluded shortly after randomisation†
Allocated to surgery (n=86)
Received allocated intervention (n=77)‡
Did not receive allocated intervention (n=9)
Analysed
Intention to treat (n=86)††
Per protocol (n=60)
Analysed
Intention to treat (n=86)
Per protocol (n=71)
Lost to follow-up at 6 weeks (n=8)
  Withdrew during treatment (n=6)
Lost to follow-up at 6 weeks (n=0)
Lost to follow-up at 3 months (n=0) Lost to follow-up at 3 months (n=9)
Screened for eligibility (n=605)
Randomised (n=179)
Excluded (n=426)*:
  Did not meet inclusion criteria (n=378)
  Refused to participate (n=48)
Allocation
Follow-up
Analysis
Enrolment
Lost to follow-up at 6 months (n=2)§ Lost to follow-up at 6 months (n=13)
Lost to follow-up at 1 year (n=4) Lost to follow-up at 1 year (n=14)¶
Lost to follow-up at 2 years (n=4)** Lost to follow-up at 2 years (n=14)¶
Fig 1 | Enrolment, randomisation, and follow-up of study patients, showing cumulative values at
two years. *Not enough degenerative change to satisfy inclusion criteria (n=29), degenerative
changes in more than two lower lumbar discs (n=80), Oswestry disability index score too low
(n=88), did not want to undergo surgery (n=28), did not want to participate in rehabilitation
(n=20), too much general pain (n=20), had previously been through similar training programme
(n=26), and other reasons (n=135; deformity, psoriasis arthritis, language problems,
coccygodynia, age, fracture, previous operation, tumour, spondylodiscitis, hip arthrosis).
†Coronary heart disease and heart attack some days after randomisation (n=1); obvious
exclusion criterion discovered some days after randomisation (n=50; earlier large abdominal
operation (n=1), not enough degenerative change to satisfy inclusion criteria (n=2),
degenerative changes in more than two lower lumbar discs (n=2). ‡One patient received one of
two disc prostheses because of bleeding. §One patient with serious vascular complication
underwent secondary leg amputation and was lost to follow-up. ¶One patient crossed over
between 6 months and 1 year and five patients between 1 year and 2 years. Five patients
underwent surgery with disc prosthesis and one patient with fusion. **Two patients underwent
surgery with instrumented fusion before two year follow-up. ††One patient excluded because
of missing baseline values and follow-up values
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pain medicine, normal reactions, coping strategies,
family and social life, and working conditions), daily
workouts for increased physical capacity (endurance,
strength, coordination, and specific training of the
abdominal muscles and the lumbar multifidus mus-
cles), and challenging patients’ thoughts about, and
participation in, physical activities previously labelled
asnotrecommended(suchaslifting,jumping,vacuum
cleaning, dancing, and ball games). Follow-up consul-
tations were conducted at six weeks, three months, six
months, and one year after the intervention. See
appendix 2 on bmj.com for detailed description of
the rehabilitation intervention.
Surgery—The surgical intervention consisted of
replacementofthedegenerativeintervertebrallumbar
disc with an artificial lumbar disc (ProDisc II, Synthes
Spine).TheProDiscconsistsofthreepieces:twometal
endplates of cobalt chromium molybdenum alloy and
a core (made from ultrahigh molecular weight poly-
ethylene) fixed to the inferior endplate after insertion.
SurgeonsusedaPfannenstielorapara-medianincision
with a retroperitoneal approach. A nearly complete
discectomywasperformedwithremovalofthecartila-
ginous endplates and a sufficient release of the poster-
ior longitudinal ligament to ensure disc space
mobilisation. A fluoroscope was used to ensure that
the prosthesis was placed in the midline and suffi-
ciently towards the posterior edge of the vertebrae.
All hospitals participating in the study used the same
artificial lumbar disc device. One surgeon at each cen-
tre had main responsibility for the operation (five cen-
tresandfivesurgeons).Surgeonswererequiredtohave
inserted at least six disc prostheses before performing
surgery in the study. There were no major postopera-
tive restrictions. Patients were not referred for post-
operative physiotherapy, but at six weeks’ follow-up
they could be referred for physiotherapy if required,
emphasising general mobilisation and non-specific
exercises.
Outcome measures
Theprimaryoutcomemeasurewaspainanddisability
measured with version 2.0 of the Oswestry disability
index,
18 translated into Norwegian and tested for psy-
chometric properties by Grotle et al.
19 (Scores range
from 0 to 100, with lower score indicating less severe
painanddisability.)Secondaryoutcomesincludedlow
back pain (measured with a visual analogue scale, ran-
ging from 0 (no pain) to 100 (worst pain imaginable))
and general health status assessed with SF-36 (scores
rangefrom0to100,higherscorescorrespondtobetter
health status)
2021 and EQ-5D (scores range from −0.59
to1(1equalsperfecthealth)).
22Forpsychologicalvari-
ables we included emotional distress (Hopkins symp-
tom check list (HSCL-25), scores range from 1 to 4,
with lower scores indicating less severe symptoms)
and the fear avoidance belief questionnaire (FABQ)
for work and physical activity (scores range from 0 to
42(work)andfrom0to24(physical),withlowerscores
indicating less severe symptoms).
2324 Self efficacy
beliefs for pain were registered by a subscale of the
arthritis self efficacy scale (scores range from 1 to 10
and are summarised and divided by 5; lower scores
indicateuncertaintyinmanagingthepain).
25Worksta-
tus was evaluated as suggested by Fritzell et al.
3 (See
table A in appendix 3 on bmj.com.) We calculated a
net back to work rate, subtracting patients who went
backtoworkfrompatientswhostoppedworking,satis-
factionwiththeresultofthetreatmentonasevenpoint
Table 1 |Baseline characteristics in patients with low back pain and degenerative disc
randomised to disc prosthesis surgery or rehabilitation. Figures are numbers (percentage)
unless stated otherwise
Surgery
(n=86)
Rehabilitation
(n=86)
Mean (SD) age (years) 41.1 (7.1) 40.8 (7.1)
Women 40 (47) 51 (59)
Mean (SD) duration of back pain (months) 76 (72 85 (74)
Education:
Primary school (9 years) 19 (22) 17 (20)
High school (12 years) 44 (51) 58 (67)
College 14 (16) 8 (9)
University 9 (11) 3 (4)
Mean (SD) body mass index (BMI) 25.6 (3.1) 25.5 (3.5)
Current smokers 42 (49) 37 (43)
Work status (working v not working):
Working (includes part time sick leave) 24 (28) 22 (26)
On sick leave 25 (29) 34 (41)
Rehabilitation 29 (34) 25 (29)
Disability pension 3 (4) 0
Homemaker 0 2 (2)
Unemployed 1 (1) 0
Student 3 (4) 0
Unknown 1 (1) 3 (4)
Comorbidity 20 (23) 21 (24)
Daily consumption of narcotics 23 (27) 17 (20)
Previous surgery 23 (27) 25 (29)
Mean (SD) ODI score 41.8 (9.1) 42.8 (9.3)
Low back pain score* 64.9 (15.3) 73.6 (13.9)
Mean (SD) SF-36 score:
Physical function 52.7 (17.6) 50.6 (17.7)
Role physical 25.3 (24.2 23.9 (18.7)
Bodily pain 24.9 (16.5) 24.4 (12.1)
General health 57.9 (19.7) 55.9 (19.9)
Vitality 37.8 (20.2) 33.1 (19.9)
Social function 53.0 (30.6) 57.6 (26.7)
Role emotion 72.5 (33.3) 67.6 (32.7)
Mental health 71.7 (18.0) 65.8 (18.9)
Physical component summary score 30.5 (7.1) 30.8 (6.5)
Mental component summary score 47.7 (13.0) 45.2 (13.2)
Mean (SD) HSCL-25 1.8 (0.5) 1.9 (0.5)
Mean (SD) FABQ work 25.9 (11.3) 27.4 (9.9)
Mean (SD) FABQ physical 14.1 (5.8) 12 (5.5)
ODI=Oswestry disability index (0 to 100, lower scores indicate less severe symptoms); SF-36=short form-36 (0
to 100, higher scores indicate better health status); HSCL-25=Hopkins symptom check list (for emotional
distress, scores range from 1 to 4, lower scores indicate less severe symptoms); FABQ=fear avoidance belief
questionnaire (scale ranges from 0 to 24 (physical) and from 0 to 42 (work), lower scores indicate less severe
symptoms).
*Calculated with horizontal scale ranging from 0 (no pain) to 100 (worst pain imaginable), with word anchors at
the beginning and end.
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Likert scale.
26 Further daily consumption of drugs was
registered. Patients attended for follow-up visits at six
weeks, three and six months, and one and two years
(the main end point of follow-up was at two years). At
two years we sent a questionnaire including the most
important outcome measures to 29 of the 34 patients
who were lost to follow-up (see table B in appendix 3
on bmj.com).
At the two year follow-up, two independent obser-
vers blinded to treatment evaluated patients using the
back performance scale (consists of five tests with a
score ranging from 0 to 15, worst possible)
27 and the
Prolo scale (consists of functional and economic parts,
whicharesummedtoaworstscoreof2andabestscore
of 10).
28 Patients were informed before this session not
to reveal the treatment received, and had tape placed
on their abdominal wall to hide the scarring from the
operation. We also carried out a full health economic
analysis, which will be reported elsewhere.
Statistical considerations
The trial was designed to have 80% power to detect a
significant difference of at least 10 points in change in
the mean Oswestry disability index score between the
intervention groups at two year follow-up.
5 Baseline
standard deviation was estimated at 18.
18 Considering
these assumptions and adding 25% for a multicentre
study design and 30% for possible drop-outs, we esti-
mated we required 180 patients.
Planned analyses
The main statistical analysis was in the intention to
treat population at one and two year follow-up.
According to our protocol the analysis was performed
withtheassumptionthatpatientswhodroppedouthad
no improvement after drop-out (last value carried for-
ward). We also determined if different centres had dif-
ferent outcomes. We used χ
2 test or Fisher’s exact test
to analyse categorical variables and independent two
sided t test or analysis of variance to analyse continu-
ous variables. A significance level of 5% was used
throughout. All statistical analyses were performed
with SPSS version 16.0. We did not adjust for signifi-
cantly different baseline scores.
Unplanned analyses (analyses not recorded in the original
protocol)
We conducted a per protocol analysis for the primary
outcomevariable(scoreonOswestrydisabilityindex).
Consistent with criteria from the Food and Drug
Administration,
8 we considered an individual change
in score of at least 15 points from baseline to two year
follow-upasaminimalimportantchange.Adeteriora-
tion of 6 points in the score was considered a “change
for the worse.”
29 We calculated the number needed to
treat with confidence intervals.
30 A mixed model ana-
lysis was used to evaluate the effect of each efficacy
Table 2 |Treatment and complications in 77 patients with low
back pain and degenerative disc randomised to disc
prosthesis surgery
Variable Surgery group
No (%) by level of operation:
L4/L5 17 (22)
L5/S1 35 (46)
L4/L5 and L5/S1 25 (33)
Median (range) operative time (min) 165 (72-570)
Median (range) blood loss (ml) 310 (50-6000)
Mean (SD) length of hospital stay (days) 7.2 (3.6)
No with complications:
Intimal lesion in left common iliac artery* 1
Arterial thrombosis of dorsalis pedis artery† 1
Dural tear 0
Blood loss >1500 ml 4
Retrograde ejaculation (at one year) 1‡
Abdominal hernia 1
Superficial haematoma 1
Ileus 1
Temporary warm left foot 2
Temporary nausea at one year follow-up 1
Neurological deterioration:
Motor deficit at two year follow-up 0
Temporary motor deficit 0
Sensory loss at two year follow-up 2
Temporary sensory loss 4
Radicular pain at two year follow-up 2
Temporary radicular pain 4
Infection:
Superficial wound infection 0
Deep wound infection 0
Urinary tract infection 0
TotalNo(%)complicationsduringtwoyearfollow-up 26 (34)
Additional spinal surgery within 2 years:
Fusion 2§
Other 2¶
*Repeat surgery with insertion of new polyethylene inlay.
†Associated with temporary slightly colder foot at follow-up.
‡One patient reported retrograde ejaculation at baseline but not at one
year follow-up, one at baseline and at follow-up, and one at follow-up
but without baseline information.
§Fusion at level with disc prosthesis and level above.
¶Resection of spinous process because of possible painful contact
between adjacent levels.
Follow-up
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Fig 2 | Primary outcome variable within intention to treat
mixed model analysis. Mean difference in Oswestry disability
index (ODI) was 6.9 points at two year follow-up, P<0.001
(adjusted for baseline index)
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model patients were not excluded from the analysis of
anefficacyvariableifthevariablewasmissingatsome,
but not all, time points after baseline. In the additional
analysis(categoricalorordinaldataattwoyearfollow-
up), missing data were not replaced. Significantly dif-
ferentbaselinescoreswerenotadjustedforinthelong-
itudinal model. Each outcome variable was adjusted
for the baseline values of the variable.
RESULTS
Of the 605 patients screened for eligibility, 173 were
included in the study and treated between April 2004
andSeptember2007(86withsurgeryand87withreha-
bilitation) (fig 1). The drop-out rate from inclusion to
two year follow-up was 20% (n=34) (15% (n=13) in the
surgicalarmand24%(n=21)intherehabilitationarm).
Five patients (6%) crossed over from rehabilitation to
surgery, but none crossed from surgery to rehabilita-
tion.Ofthe34patientslosttofollow-up,26answereda
questionnaire two and a half to five years after treat-
ment (see table B in appendix 3 on bmj.com).
Patients’ characteristics
Most baseline characteristics were similar in the two
treatment groups (table 1). Low back pain score and
SF-36 mental health subscores, however, were signifi-
cantlyworseintherehabilitationgroupthaninthesur-
gery group.
Surgical treatment and complications
Ofthepatientsrandomisedtosurgery,25(33%)under-
went two level surgery. Median surgical time was
165 minutes (range 72-570 minutes) and median
blood loss was 310 ml (range 50-6000 ml) (table 2).
Four patients had bleeding of more than 1500 ml.
Six patients (8%) had complications resulting in
impairmentattwoyearfollow-up,andthereoperation
ratewas6.5%(n=5)(table 2).Onepatienthadaserious
complication: at the three month follow-up, the poly-
ethylene inlay was found to be dislodged.During revi-
sion surgery, injury to the left common iliac artery led
to compartment syndrome resulting in a lower leg
amputation. One patient reported retrograde ejacula-
tion at one year follow-up. At two year follow-up, two
patients reported sensory loss in the thigh and two
patients reported new radicular pain. In addition, one
patient had an arterial thrombosis of the dorsalis pedis
artery, which temporarily resulted in a slightly colder
foot. Table 2 presents further complications. Two
patients had an additional fusion and two patients
had partial resection of the spinous processes because
of persistent back pain.
Primary outcome
Planned analyses according to protocol
The mean change Oswestry disability index score
frombaselinetotwoyearfollow-upwas20.8(95%con-
fidence interval 16.4 to 25.2) in the surgery group and
12.4 (8.5 to 16.3) in the rehabilitation group (table 3).
Themeantreatmenteffect(differencebetweengroups)
at two year follow-up was −8.4 (−13.2 to −3.6) in the
intention to treat analysis (last value carried forward).
Subgroup analysis showed no differences in the main
outcome variable between centres and level(s) oper-
ated on.
Unplanned analyses
In the mixed model analysis, the Oswestry score
improved significantly more in the surgical group
than in the rehabilitation group at all time points, in
both the intention to treat (fig 2) and per protocol ana-
lyses (table 4). The mean change from baseline to two
year follow-up was 22.5 (intention to treat) (95% con-
fidence interval 18.5 to 26.4) in the surgery group and
15.6 (intention to treat) (11.7 to 19.5) in the rehabilita-
tion group. The mean treatment effect (difference
between groups) at two year follow-up was 6.9 (2.1 to
11.7) in the intention to treat analysis. In an analysis in
Table 4 |Unplanned analysis of primary outcome in patients with low back pain and degenerative disc randomised to disc
prosthesis surgery or rehabilitation. Mean (SD) outcome values on Oswestry disability index (ODI) at follow-up and
treatment effect (difference (95% confidence interval)), minus values indicating larger improvement in outcome with surgery
Intention to treat analysis Per protocol analysis
Surgery Rehabilitation Treatment effect Surgery Rehabilitation Treatment effect*
Baseline 41.8 (9.1) 42.8 (9.3) — 42.2 (9.2) 42.1 (8.3) —
6 weeks 31.5 (17.2) 30.2 (13.6) 1.3 (−3.5 to 6.1) 31.1 (17.3) 29.6 (13.5) 1.7 (−3.1 to 6.6)
3 months 21.5 (14.1) 30.6 (13.1) −9.1 (−13.9 to −4.3) 20.7 (13.5) 30.3 (12.7) −9.5 (−14.4 to −4.6)
6 months 21.4 (16.3) 31.1 (14.9) −9.7 (−14.6 to −4.8) 20.7 (15.9) 29.9 (14.6) −9.2 (−14.2 to −4.2)
1 year 20.3 (17.2) 29.2 (16.1) −8.9 (−13.8 to −4.0) 19.7 (16.4) 27.0 (15.0) −7.3 (−12.3 to −2.3)
2 years 19.8 (16.7) 26.7 (14.5) −6.9 (−11.7 to −2.1) 18.8 (15.8) 26.9 (13.9) −8.1 (−12.9 to −3.2)
ODI=see footnote for table 1 for scale details.
*All P<0.001 for trend in treatment effect over time. Two sided t test.
Table 3 |Planned analysis of primary outcome in patients with low back pain and
degenerative disc randomised to disc prosthesis surgery or rehabilitation. Mean (SD)
outcome values on Oswestry disability index (ODI) at 12 and 24 months and treatment effect
Mean outcome
Treatment effect* (95% CI) P value† Surgery Rehabilitation
Baseline 41.8 (9.1) 42.8 (9.3) ——
1y e a r 2 2 . 3( 1 7 . 0 ) 3 3 . 0( 1 6 . 6 ) −10.0 (−15.0 to −5.0) <0.001
2 years 21.2 (17.1) 30.0 (16.0) −8.4 (−13.2 to −3.6) 0.001
ODI=see footnote for table 1 for scale details.
*Difference between groups in mean change from baseline.
†Two sided t test.
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worst score in the group, the difference between the
groups remained significant (P<0.001). Some 70%
(n=51) of the patients in the surgery group and 47%
(n=31) of the patients in the rehabilitation group had
animprovementinOswestryscoreofatleast15points
(P<0.006) (intention to treat). The number needed to
treat was 4.4 (2.6 to 14.5). Worsening of low back pain
was experienced by 11% (n=8) of the surgical group
and 9% (n=6) of the rehabilitation group. Subgroup
analysis showed no differences in the main outcome
variable between centres and level(s) operated on.
Secondary outcomes
Planned analyses according to protocol
Lowbackpain,SF-36physicalsummary,andpatients’
satisfactionimprovedsignificantlymoreinthesurgical
groupthan the rehabilitation groupat twoyearfollow-
up (table 5). The mean difference between the groups
in change from baseline to two year follow-up was
−12.2 (95% confidence interval −21.3 to −3.1) for low
back pain and 5.8 (2.5 to 9.1) for SF-36 physical sum-
mary. On the seven point global rating scale at two
years, 63% (46) of patients in the surgery group and
39% (26) in the rehabilitation group (P=0.005 for dif-
ference between treatment groups) considered them-
selves completely recovered or much improved. Self
efficacy for pain favoured the surgical group. SF-36
mental summary, EQ-5D, FABQ work and physical,
HSCL-25, return to work, and drug consumption did
not differ at two year follow-up. At the start of the
study, 28% (46) of patients were at work full or part
time; at two year follow-up, this had increased to 56%
(n=74). There was a “net back to work” rate of 31%
(n=21) in the surgical group and 23% (n=15) in the
rehabilitation group (P=0.31) (table 5). Scores on the
back performance scale did not differ significantly
between the groups (−0.8, −1.8 to 0.2; P=0.10). The
Prolo sum score favoured the surgical group, with a
mean difference of 0.9 (0.1 to 1.6; P=0.019).
Unplanned analyses
In the mixed model analysis, low back pain (table 6),
SF-36physicalsummary(table 8),andEQ-5D,HSCL-
25, and self efficacy for pain (table 9) improved signif-
icantly more in the surgical group than the rehabilita-
tion group at all time points. The mean difference
between the groups in change from baseline to two
year follow-up for low back pain was −12.7 (95% con-
fidence interval −21.1 to −4.2, table 6) and SF-36 phy-
sicalsummary4.3(0.8to7.9,table 8).Furtheranalyses
are shown in tables 7, 8, and 9.
DISCUSSION
This randomised trial comparing disc prosthesis with
multidisciplinary rehabilitation showed a significant
difference in the primary outcome variable (Oswestry
disability index after two years) in favour of surgery.
The difference between groups of 8.4 points on the
index (with intention to treat analysis) at two year fol-
low-up,however,wassmallerthanthe differenceof10
Table 5 |Planned analysis of secondary outcomes in patients with low back pain and
degenerative disc randomised to disc prosthesis surgery or rehabilitation. Mean (SD) values
at 12 and 24 months (unless stated otherwise) and treatment effect
Variable
Mean outcome Treatment effect
(95% CI)* P value† Surgery Rehabilitation
Back pain score‡:
Baseline 64.9 (15.3) 73.6 (13.9)
1 year 35.6 (28.6) 53.2 (28.4) −14.0 (−23.0 to −5.0) 0.003
2 years 35.4 (29.1) 49.7 (28.4) −12.2 (−21.3 to −3.1) 0.009
SF-36 physical component summary:
Baseline 30.5 (7.1) 30.8 (6.5)
1 year 42.8 (12.2) 37.3 (11.0) 5.5 (1.9 to 9.1) 0.003
2 years 43.3 (11.7) 37.7 (10.1) 5.8 (2.5 to 9.1) 0.001
SF-36 mental component summary‡:
Baseline 47.7 (13.0) 45.2 (13.2)
1 year 50.2 (12.0) 49.2 (13.2) 0.2 (−3.5 to 3.8) 0.90
2 years 50.7 (11.6) 48.6 (12.8) 1.0 (−2.4 to 4.4) 0.50
EQ-5D:
Baseline 0.30 (0.27) 0.27 (0.31)
1 year 0.68 (0.34) 0.55 (0.32) 0.13 (0.01 to 0.25) 0.04
2 years 0.69 (0.33) 0.63 (0.28) 0.06 (−0.05 to 0.18) 0.26
HSCL-25
Baseline 1.81 (0.50) 1.88 (0.51)
1 year 1.51 (0.49) 1.67 (0.52) −0.12 (−0.26 to 0.02) 0.10
2 years 1.50 (0.44) 1.63 (0.52) −0.10 (−0.23 to 0.04) 0.20
FABQ work:
Baseline 25.8 (11.2) 27.4 (27.4)
1 year 19.2 (14.2) 23.1 (13.0) −2.7 (−6.5 to 1.1) 0.20
2 years 18.1 (13.9) 21.2 (12.8) −2.1 (−6.0 to 1.7) 0.30
FABQ physical:
Baseline 14.0 (5.8) 12.5 (5.6)
1 year 8.8 (6.7) 9.7 (5.8) −1.3 (−3.2 to 0.6) 0.20
2 years 9.0 (6.8) 9.9 (6.0) −1.5 (−3.4 to 0.5) 0.10
Self efficacy:
Baseline 3.4 (1.5) 3.6 (1.6)
1 year 6.3 (3.3) 5.2 (2.4) 1.2 (0.3 to 2.1) 0.01
2 years 6.1 (2.9) 5.3 (2.5) 1.0 (0.2 to 1.9) 0.02
No (%) returned to work at 2 years§: 2 1( 3 1 ) 1 5( 2 3 ) — 0.31
No (%) satisfied with outcome
at 2 years¶
46 (63) 26 (39) — 0.005
No (%) satisfied with care at 1 year** 66 (90) 48 (73) — 0.011
No (%) with drug consumption
at 2 years††
16 (22) 14 (18) — 0.30
Back performance scale at 2 years‡‡ 3.2 (3.0) 4.0 (3.0) −0.8 (−1.8 to 0.2) 0.10
Prolo scale at 2 years§§ 7.0 (2.3) 6.1 (1.9) 0.9 (0.1 to 1.6) 0.019
ED-5Q score ranges from −0.59 to 1 (1 equals perfect health); self efficacy beliefs for pain scores ranges from 1
to 10 and are summarised and divided by 5. Lower scores indicate that he/she is very uncertain if he/she is
able to manage pain. For other scores see footnote to table 1.
*Treatment effect is difference between groups in mean change from baseline. Positive value in SF-36, EQ-5D,
self efficacy for pain, and Prolo scale and negative values in remaining variables indicate larger improvement in
outcome with surgery.
†Two sided t test for continuous variables and Pearson’s χ
2 test for categorical variables.
‡Values not adjusted for significantly different baseline scores.
§Net back to work rate calculated by subtracting patients who went back to work from patients who stopped
working.
¶7 point Likert scale (1=completely recovered, 2=much recovered to 7=vastly worsened); slightly improved not
included as satisfied with outcome.
**4 point global rating scale, not including slightly satisfied as satisfied with care.
††Use of drugs daily or not.
‡‡Scale comprises five tests with score ranging from 0 to 15 (worst possible).
§§Scale comprises functional and economic parts, summed to give worst score of 2 and best score of 10.
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intheconfidenceintervals,thedataareconsistentwith
awiderangeofdifferencesbetweenthegroups,includ-
ing values well below 10 points. There is, as far as we
know,noagreementonthesizeoftheclinicallyimpor-
tant difference between two treatment groups. As an
alternative we can assess the proportion of patients
achieving a clinically meaningful improvement.
31 By
usingaclinicallymeaningfulimprovementforanindi-
vidual patient of 15 points on the Oswestry disability
index,
870%(n=51)ofpatientsinthesurgicalgroupand
47% (n=31) of those in the rehabilitation group
achieved at least this improvement (intention to
treat). We will publish data on the estimated minimal
clinicallyimportantchangeelsewhere,butthechanges
are in agreement with recommendations from FDA
studies. As there is no consensus based agreement of
howlargeadifferencebetweengroupsmustbetobeof
clinical importance it is impossible to conclude
whether the effect found in our study is of clinical
importance. As such a decision must be made before
a new treatment can be recommended in clinical prac-
tice;ourstudyunderlinestheneedforsuchaconsensus
agreement.
ThechangeintheOswestrydisabilityindexscorein
our study is comparable with those seen in previous
studies. In our study, the mean score was reduced by
29%(12.4points)intherehabilitationgroup(intention
to treat analysis). Brox et al
4 found a similar reduction
of 29% (12.0 points) at one year follow-up, while Fair-
bank et al
6 and Fritzell et al
3 observed a smaller reduc-
tion at two year follow-up (8.7 and 5.5 points,
respectively).Inourstudy,therewasameanreduction
in score of 50% (20.8 points) in the surgical arm (inten-
tion to treat analysis). Similar reductions have been
reported in other studies,
8911though Zigler et al used
the “chiropractor version” of the Oswestry index.
32
This questionnaire has not been sufficiently validated
and consequently it is difficult to compare the
outcome.
18
It could be argued that patients who withdrew after
randomisation or dropped out during or after treat-
menthadasuperiororinferioroutcome.Wetherefore
senta questionnairetosuchpatients.Theninepatients
whowithdrewaftersurgeryexperiencedareductionin
Oswestry score of 30.2 (SD 4.5) points. The six who
withdrew after rehabilitation had a reduction of 11.8
(SD 3.0), and the 11 patients who withdrew without
treatment had no change (1.0 (SD 4.5) points) (see
tableBinappendix3onbmj.com).Thismightsupport
the assumption of no improvement in outcome after
drop-out,justifyinguseofthelastvaluecarriedforward
analysis.
Most changes in secondary variables measuring dis-
ability and pain favoured surgical treatment, though
there were no significant differences between groups
in FABQ work, FABQ physical, SF-36 mental health,
EQ-5D, HSCL-25, drug consumption, return to work,
andthebackperformancescaleinthemainanalysis.In
the surgical group we found a similar “net back to
work” rate as reported by Fritzell et al.
3 Nevertheless,
it has been argued that sick leave, to a large extent, is
influenced by factors outside the domain of medical
andtherapeuticinterventions.
33Thesomewhatsmaller
difference between groups in the back performance
scale than in the Oswestry disability index might be
explained by differences in psychometric properties
between the outcome measurements or by patients
overstating the effect in a subjective questionnaire.
Table 6 |Unplanned analysis in secondary outcome in
patients with low back pain and degenerative disc
randomised to disc prosthesis surgery or rehabilitation.
Mean (SD) outcome values for back pain* at follow-up and
treatment effect (difference (95% confidence interval))
Intention to treat analysis
Surgery Rehabilitation Treatment effect†
Baseline 64.9 (15.3) 73.6 (13.9) —
6 weeks 34.7 (27.5) 51.1 (24.6) −16.5 (−24.8 to −8.2)
3 months 29.3 (25.0) 55.4 (23.4) −26.2 (−34.5 to −17.8)
6 months 36.1 (28.5) 50.0 (24.5) −13.8 (−22.3 to −5.3)
1 year 33.0 (29.4) 48.7 (28.9) −15.7 (−24.3 to −7.0)
2 years 32.7 (28.8) 45.3 (28.6) −12.7 (−21.1 to −4.2)
*See table 1 for score details.
†Negative values indicate larger improvement in outcome with surgery.
All P<0.001 for trend in treatment effect over time. Two sided t test.
Table 7 |Unplanned analysis in secondary outcomes in patients with low back pain and degenerative disc randomised to disc prosthesis surgery or
rehabilitation. Mean (SD) outcome values for SF-36*
Variable
Baseline 3 months 6 months 1 year 2 years
P value† Surgery Rehabilitation Surgery Rehabilitation Surgery Rehabilitation Surgery Rehabilitation Surgery Rehabilitation
Physicalfunction 52.7 (17.6) 50.6 (17.8) 76.2 (18.3) 64.0 (22.4) 76.0 (21.4) 63.7 (21.0) 79.5 (20.6) 66.7 (22.9) 78.9 (20.2) 69.6 (22.2) <0.001
Role physical 25.3 (24.2) 23.9 (18.7) 50.0 (31.5) 45.6 (31.9) 57.2 (35.1) 47.8 (31.2) 58.9 (37.3) 55.9 (33.9) 66.4 (33.5) 55.1 (35.0) 0.135
Bodily pain 24.9 (16.5) 24.4 (12.1) 48.2 (22.4) 34.9 (16.1) 50.8 (29.1) 39.1 (20.8) 52.5 (30.8) 43.5 (24.6) 55.5 (29.1) 44.4 (23.0) <0.001
General health 57.9 (19.7) 55.9 (19.9) 67.6 (22.8) 60.7 (24.7) 65.5 (24.3) 60.1 (24.4) 68.1 (26.8) 61.7 (22.1) 65.7 (26.0) 61.1 (24.8) 0.125
Vitality 37.8 (20.2) 33.1 (20.0) 50.3 (21.6) 44.4 (22.1) 55.6 (23.7) 45.7 (22.9) 57.5 (27.5) 48.2 (24.9) 55.0 (27.1) 46.8 (23.5) 0.003
Social function 53.0 (30.6) 57.6 (26.7) 72.8 (25.0) 68.8 (25.6) 75.0 (28.6) 71.1 (26.7) 76.7 (25.7) 74.3 (26.8) 78.3 (26.8) 77.9 (27.4) 0.725
Role emotion 72.5 (33.3) 67.6 (32.7) 85.1 (23.3) 69.0 (34.7) 83.3 (26.3) 74.5 (29.8) 80.4 (31.0) 79.2 (26.3) 83.9 (25.6 ) 79.2 (29.0) 0.010
Mental health‡ 71.7 (18.0) 65.8 (18.7) 78.6 (15.6) 72.4 (17.9) 79.5 (16.8) 74.1 (16.4) 80.4 (17.5) 73.8 (20.9) 78.3 (18.2) 75.8 (17.5) 0.007
*See table 1 for score details.
†For trend in treatment effect over time.
‡Values are not adjusted for significantly different baseline scores.
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Ourstudyhasseveralstrengths.Itwasrandomisedand
had few patients who crossed over to the other treat-
ment regimen. In addition, an independent research
assistant collected the data, the observers at the two
year evaluation were blinded, the interventions were
standardised,andthefinancingofthestudywaspublic.
Choosing magnetic resonance imaging criteria for
inclusion could be a strength or limitation. To our
knowledge, there are no specific criteria to determine
which degenerative changes should be operated on.
When designing the study we wanted the inclusion of
patients across centres to be as unanimous as possible,
treating the same population, although this possibly
would lead to less external validity of the study. It
could also possibly lead to inclusion of more severe
degenerated discs in our study compared with other
studies.
89
Onelimitationofourstudyisthelackofaplaceboor
sham group. The regression to the mean and the nat-
ural resolution of chronic low back pain must also be
considered in both groups. When balancing a non-
operative regimen with an operative treatment, there
isprobablyadifferenceinplaceboeffectthatisdifficult
to untangle from the treatment effect.
34-37 The placebo
effect might be higher in the surgical group, although
the possible placebo effect of rehabilitation over sev-
eral weeks with personal contact with a therapist
should not be underestimated. Furthermore, it could
be argued that the patients included in the study
wanted surgery, but the number of patients not want-
ing the rehabilitation programme was similar to the
number of patients not wanting surgery (see figure
and appendix 1 on bmj.com). Brox et al found no dif-
ference in treatment effect between patients who did
and did not “believe” in surgery,
45and a recent study
found no significant relation between baseline
expectations and follow-up scores.
38 On the other
hand, “expectation being fulfilled” might be a predic-
tor of global outcome.
38 During the inclusion process,
we emphasised the advantages and disadvantages of
the two treatment options and that none of the treat-
ments are documented as superior to another. It is still
possible, however, that patients in the rehabilitation
group found themselves faced with “more of the
same.”Thelackofroutinerehabilitationinthesurgical
arm could be another limitation in the study. We
wanted to avoid the postoperative treatment contain-
ing elements from the rehabilitation programme.
Hence, patients received only general advice when
they were discharged from the hospital and received
no rehabilitation in the first weeks after surgery. At
six weeks, however, patients could be referred if
required to a physiotherapist at their home for func-
tional mobilisation and general muscle training.
Table 8 |Unplanned analysis in secondary outcome in
patients with low back pain and degenerative disc
randomised to disc prosthesis surgery or rehabilitation.
Mean (SD) outcome values for physical and mental
component summary scores on SF-36* at follow-up and
treatment effect (difference (95% confidence interval))
Surgery Rehabilitation Treatment effect†
SF-36 physical component summary
Baseline 30.5 (7.1) 30.8 (6.5) —
3 months 40.3 (10.9) 37.3 (8.9) 3.0 (−0.6 to 6.6)
6 months 41.4 (12.3) 37.2 (9.2) 4.2 (0.6 to 7.8)
1 year 43.5 (12.7) 39.4 (11.5) 4.2 (0.6 to 7.7)
2 years 43.9 (11.9) 39.6 (10.4) 4.3 (0.8 to 7.9)
SF-36 mental component summary
Baseline 47.7 (13.0) 45.2 (13.2) —
3 months 50.9 (10.4) 47.0 (12.9) 3.9 (−0.2 to 8.0)
6 months 52.0 (9.7) 49.5 (10.5) 2.5 (−1.6 to 6.6)
1 year 51.7 (11.6) 49.7 (12.0) 2.0 (−2.0 to 6.1)
2 years 51.0 (11.0) 50.5 (11.0) 0.5 (−3.4 to 4.5)
*See table 1 for score details.
†Positive treatment effect indicates larger improvement in outcome for
surgery. P=0.002 for physical and 0.166 for mental for trend in treatment
effect over time.
Table 9 |Secondary outcomes in patients with low back pain
and degenerative disc randomised to disc prosthesis surgery
or rehabilitation. Mean (SD) outcome values on EQ-5D, HSCL-
25, FABQ, and self efficacy at follow-up and treatment effect
(difference (95% confidence interval))
Variable* Surgery Rehabilitation Treatment effect†
EQ-5D‡ ‡
Baseline 0.30 (0.30) 0.27 (0.31) —
6 weeks 0.59 (0.30) 0.55 (0.29) 0.04 (−0.06 to 0.15)
3 months 0.70 (0.23) 0.48 (0.31) 0.22 (0.12 to 0.33)
6 months 0.68 (0.28) 0.51 (0.33) 0.17 (0.06 to 0.27)
1 year 0.67 (0.35) 0.54 (0.32) 0.13 (0.02 to 0.23)
2 years 0.68 (0.34) 0.60 (0.30) 0.08 (−0.03 to 0.18)
HSCL-25§ §
Baseline 1.81 (0.50) 1.88 (0.51) —
3 months 1.38 (0.34) 1.66 (0.51) −0.27(−0.44to −0.11)
6 months 1.44 (0.45) 1.66 (0.49) −0.22(−0.38to −0.05)
1 year 1.45 (0.50) 1.59 (0.49) −0.14 (−0.30 to 0.03)
2 years 1.47 (0.49) 1.55 (0.50) −0.09 (−0.25 to 0.08)
FABQ work§ §
Baseline 25.8 (11.2) 27.4 (9.9) —
3 months 20.0 (12.9) 24.3 (11.9) −4.3 (−8.6 to 0.1)
6 months 18.7 (12.9) 23.0 (12.7) −4.3 (−8.7 to 0.1)
1 year 18.2 (13.9) 21.3 (13.2) −3.1 (−7.4 to 1.2)
2 years 16.7 (13.5) 18.5 (12.5) −1.8 (−6.1 to 2.5)
FABQ physical§ §
Baseline 14.0 (5.8) 12.5 (5.6) —
3 months 8.8 (5.3) 9.1 (6.3) −0.3 (−2.4 to 1.7)
6 months 8.6 (6.3) 9.3 (6.7) −0.7 (−2.8 to 1.3)
1 year 8.0 (6.3) 8.9 (5.8) −0.8 (−2.9 to 1.2)
2y e a r s 8 . 0( 6 . 0 ) 8 . 3( 5 . 7 ) −0.3 (−2.3 to 1.7)
Self efficacy‡ ‡
Baseline 3.4 (1.5) 3.6 (1.6) —
3 months 6.1 (2.3) 5.0 (2.2) 1.0 (0.2 to 1.9)
6 months 6.0 (2.6) 5.6 (2.4) 0.5 (−0.3 to 1.3)
1 year 6.4 (3.3) 5.5 (2.5) 0.9 (0.0 to 1.7)
2 years 6.2 (2.7) 5.6 (2.7) 0.5 (-1.4 to 2.8)
*See tables 1 and 5 for score details.
†EQ-5D P<0.001, HSCL P<0.001, FABQ work P=0.057, FABQ physical
P=0.548, self efficacy P=0.019 for trend in treatment effect over time.
‡Positive scores indicate larger improvement in outcome with surgery.
§Negative scores indicate larger improvement in outcome with surgery.
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ondoperationbutrepeatrehabilitationwasnotconsid-
ered. Patients did not request a second chance for
rehabilitation, though they were advised during fol-
low-up consultations. Another weakness in our study
isthedifferenceincompliancebetweengroupsandthe
high drop-out rate. This difference in adherence to the
protocolprobablyleadstoanunderestimateofthetrue
effectofsurgery,especiallyintheintentiontotreatana-
lysis.Insimilarstudiescomparingsurgerywithrehabi-
litation, the drop-out rates were similar to ours.
639-41
The patients we included in our study were highly
selected, with one or two level degenerative changes
and good general health. Thus, our results are valid
only in similar patients. Furthermore, we examined
several secondary outcome variables that could lead
to the detection of differences by chance. Although
we conducted several unplanned analyses (not
recorded in the original protocol), in common with
similar studies, we consider it as an important asset to
our data. Lately, similar studies have applied repeated
measurements by using mixed models.
40 Using
unplanned analysis could be considered a weakness,
but our findings in these analyses support our main
analyses and strengthen our conclusion. Nevertheless,
caution should be used in interpreting the results of
non-prespecified analyses.
Potential harms of disc prosthesis surgery
Surgery carries a risk of serious complications, as seen
inoneofourpatients.InareviewbyInamasuetal,the
perioperative vascular injury rate for anterior lumbar
interbody fusion was 0-18% (mean 3%).
42 This is an
important drawback of surgery. No major differences
in complication rates between insertion of a disc pros-
thesis and fusion have been found in a randomised
setting.
8911 The short term reoperation rate in our
study was 6.5% (n=5) and the vascular injury rate was
6.5% (n=5) (table 2). Although vascular complications
are reported, serious consequences like amputation
and mortality are rare.
43 Recently Kurtz et al looked
at the rates of short term revision and mortality total
disc replacement.
43 They found similar reoperation
rates as with anterior fusion surgery and hip arthro-
plasty. Four retrospective studies have reported long
term reoperation rates of up to 13%.
44-47 Data on the
anterior revision rate of the prosthesis is difficult to
extract from these studies but seems considerably
lower. The potential long term revision rate with a
higher complication rate on revisions needs to be
considered.
48
Earlier addressed but unresolved questions are the
incidenceofadjacentleveldegenerationaftertotaldisc
replacement and distinct characteristics of patients
associated with good outcome. Some studies have
examined these issues but more information is
needed.
49-51 In a univariate analysis we found indica-
tions that patients with Modic I or II changes have a
superior result in the surgical arm and that patients
with high Oswestry scores seem to be more suitable
for rehabilitation. A full multivariate analysis of good
outcomeswill bepublishedsoonto answertheseques-
tions. Another important issue is the incidence of
degeneration in the facet joints of the operated level.
An analysis of adjacent level degeneration and degen-
eration of the operatedlevel in addition to a full health
economic analysis will be published later.
The total blood loss and operation time were higher
inourstudythaninsimilarstudies.Thelearningcurve
might be quite flat, and perhaps the participating sur-
geons should have carried out disc prosthesis surgery
in more patients before the start of the study. Using a
surgeontoexposethedisc(accesssurgeon),mightalso
have reduced the blood loss and operation time. Blu-
menthal et al and Zigler et al performed one level sur-
gery, while a third of our patients underwent two level
surgery.
89 This could explain some of the increased
blood loss and operation time in our study. Because
of the complexity of the surgery and the risk of serious
complications, we think this kind of surgery should be
confined to a few specialist centres with experienced
spine surgeons and available vascular surgeons. A
highqualityrehabilitationprogrammeshouldbeavail-
able.
Our study was not designed to evaluate specific
mechanisms of reduction of pain and disability. Possi-
ble explanations for the pain reduction are removal of
the disc in the surgical group and better coping in the
rehabilitation group, but the patients were heteroge-
neous and probably had a mixed aetiology difficult to
separate.Eventhoughwedidnothaveacontrolgroup,
themixedcausesofchroniclowbackpain,theassocia-
tion of surgery with potentially serious complications,
and the considerable improvement in the rehabilita-
tion group suggest that it is reasonable to consider a
rehabilitation programme before surgery.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
In patients with chronic low back pain, compared with fusion, the clinical outcome with disc
prosthesis has been at least equivalent
Compared with multidisciplinary rehabilitation, improvement in disability and pain are
similar
WHAT THIS STUDY ADDS
Surgery with disc prosthesis resulted in a significantly greater improvement in scores on the
Oswestry disability index and variables measuring disability and pain, although the
difference in Oswestry score between groups was lower than the study was designed to
detect
There were no differences in return to work and several outcomes measuring mental health
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